Cycle on Jul 29, 2026

I will start by listing the topic's open threads to see if there are any specific user-prioritized research questions or active watches we need to address in this cycle.

I will search for the outcomes and updates regarding Capricor Therapeutics' deramiocel CTGTAC advisory committee meeting (which is scheduled for today, July 29, 2026) and Replimune's RP1 FDA advisory committee meeting.

I will fetch the details of the FDA Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) vote on Capricor's deramiocel from the NeurologyLive and Endpoints News articles to get the specific quotes and details.

I will fetch the Endpoints News or STAT News article on the Capricor Advisory Committee vote to get the details of the vote and the specific reasons why the committee voted against deramiocel. Let's try fetching the Endpoints News or STAT News article. Let's first search for more articles to find another accessible URL or try fetching the BioSpace or STAT News one. I'll search for the STAT News live blog.

I will fetch the Fierce Biotech article since it's very recent and likely has the details of the 9-3 vote, the statistical confusion, and the arguments presented during the Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) meeting.

This is an incredible, highly detailed, and very recent primary source that directly addresses an active watch in our system: `FDA advisory committee meeting for Capricor's deramiocel in DMD cardiomyopathy` (id `019f061f-f34a-7079-a276-d216329928b2`) and `FDA final regulatory decision on Capricor's deramiocel BLA in DMD cardiomyopathy` (id `019faae7-d4d4-7d74-a6b7-85d81f6821f0`). The advisory committee met today, July 29, 2026, and voted 9-3 against deramiocel's efficacy in DMD-associated cardiomyopathy. Let's also look into the other late-July advisory committee watch: `FDA advisory committee meeting scheduled for late July 2026 to discuss Replimune's resubmitted BLA for RP1 in advanced melanoma, ahead of the August 2, 2026 PDUFA target action date` (id `019f0620-007b-7dab-87b4-0363a2496ea1`). Let's search for "Replimune" "RP1" OR "ipsimogene" "advisory committee" OR "adcomm" OR "FDA" July 2026.

This is very interesting. The Replimune advisory committee meeting is scheduled for tomorrow, July 30, 2026. The FDA staff briefing documents were published on July 28, 2026, and they reiterate severe doubts about the efficacy of RP1 (vusolimogene oderparepvec) in advanced melanoma. Let's do a search for any other recent major health, science, or biotech news from the last few days to see what other breakthroughs, drug approvals, or public health policies have occurred in late July 2026. Let's do a general search. I can search for "FDA approval" or "Phase 3 results" or other topics with `sort="recent"` and `freshness="week"`. Let's refine the search.

Let's look at the Space.com article about the Roman Space Telescope, which is scheduled to launch on August 30, 2026. This is a massive milestone in space science! Let's fetch the Space.com article.

Let's search for "Roman Space Telescope" "August 30" 2026 to see if there is another article or if the launch is indeed ready. Let's do a quick search.

This is incredibly exciting! The Nancy Grace Roman Space Telescope has completed critical fueling at NASA's Kennedy Space Center as of July 27, 2026, and is officially ready for launch on August 30, 2026, aboard a SpaceX Falcon Heavy rocket. It is launching 8 to 9 months ahead of schedule and under budget! This is a major milestone in space science. Let's check if there are any other updates on the watches we are tracking. First, let's look at: - `Vera Therapeutics Phase 3 ORIGIN 3 eGFR confirmatory results in IgAN` (id `019f3ec3-9518-7baa-a4e4-19e437e0557f`) Let's search for "Vera Therapeutics" OR "atacicept" "ORIGIN 3" OR "ORIGIN" July 2026.

Let's search for "Vera Therapeutics" "Trutakna" OR "atacicept" "July 2026" OR "July 7, 2026" FDA to see if it was approved! Yes, it says "The U.S. Food and Drug Administration has approved... atacicept-vymj (Trutakna) BLA approval; Accelerated Approval, Breakthrough" on July 7, 2026. Let's search specifically for the FDA approval of Trutakna / atacicept in July 2026.

The FDA granted accelerated approval to Vera Therapeutics' Trutakna (atacicept-vymj) on July 7, 2026. This is a massive development in the IgAN (IgA nephropathy) market! Let's see if we have a watch or a thread about this. Ah! We have: `Vera Therapeutics Phase 3 ORIGIN 3 eGFR confirmatory results in IgAN` (id `019f3ec3-9518-7baa-a4e4-19e437e0557f`, fire date `2026-09-30T00:00:00Z`). The description says: "Monitor the readout of the confirmatory eGFR kidney function data from Vera Therapeutics' Phase 3 ORIGIN 3 trial of Trutakna (atacicept) in primary IgA nephropathy, expected in Q3 2026. This is required to support its accelerated approval." Wait, does the accelerated approval announcement mention the confirmatory eGFR readout, or are they still waiting for the full 2-year eGFR readout to support traditional approval? Let's check the details of the approval. The press release says: "This accelerated approval is based on reduction of proteinuria. [...] ORIGIN 3 is an ongoing global, multicenter, randomized, double-blind, placebo-controlled Phase 3 trial of adults with IgA nephropathy." The watch is for the *readout of the confirmatory eGFR kidney function data* from Vera's Phase 3 ORIGIN 3 trial, which is expected in Q3 2026. The accelerated approval was based on the interim proteinuria data from ORIGIN 3. So the watch itself hasn't fired yet (the full confirmatory eGFR data is still expected in Q3 2026 or later, though the accelerated approval has already been granted). Wait! Let's check if there are any other updates. Let's search for "Amgen" "Tavneos" retraction EMA hearing deadline (slug: `amgen-tavneos-retraction-ema-revocation-hearing-deadline`), which is one of the prior findings. Let's search for Amgen Tavneos July 2026.

This is extremely helpful. We have a prior finding: `amgen-tavneos-retraction-ema-revocation-hearing-deadline` (Amgen's Tavneos Faces Retraction and EMA Revocation Ahead of Critical FDA Hearing Deadline). Let's see: on July 23, 2026, Amgen formally submitted its data package to the FDA challenging the proposed withdrawal of Tavneos (avacopan). The new updates show that Amgen submitted a third-party review of avacopan's pivotal trial data and other real-world analyses (including two medRxiv preprints published on July 22, 2026) to defend the drug against the FDA's proposed withdrawal. This is a very direct and important update to the existing story. Let's fetch the Fierce Pharma article about Amgen's Tavneos defense to get concrete details and quotes.

This is an incredibly rich update. I will update the note for `amgen-tavneos-retraction-ema-revocation-hearing-deadline` using this detailed, very recent primary evidence. Let's check if there are any other updates or new topics. Let's see: we have a watch on: - `New Zealand H5N1 transmission to poultry or wildlife sanctuaries` (id `019f776d-f69b-75cf-93b1-ae8e6c95e559`) - `Australia H5N1 transmission to poultry or local wildlife` (id `019f2f50-7f4d-7361-8f05-cdf170c2d727`) Let's do a search for "H5N1" "New Zealand" OR "Australia" fresh in the last week.

This is a huge development! Let's see: 1. "Australia confirms local transmission of H5N1 bird flu among native greater crested terns in South Australia." 2. "Australia said on Wednesday [July 29, 2026] the deadly H5N1 bird flu virus is being transmitted locally in the native bird population." 3. "New Zealand to Require Biosecurity Plans From Poultry Sector as Australia's H5N1 Count Rises to 27." 4. "Queensland became Australia's fourth state to confirm a case of H5N1 bird flu after authorities said on Saturday that a migratory seabird tested positive..." This directly triggers and fires our ongoing watch: `Australia H5N1 transmission to poultry or local wildlife` (id `019f2f50-7f4d-7361-8f05-cdf170c2d727`). The watch trigger is: "Fires when Australia confirms the transmission of H5N1 to commercial poultry flocks, native land birds, or local marine mammal colonies." Since Australia has now confirmed local transmission among native greater crested terns (native birds/local wildlife), this watch has fired! And we have: `New Zealand H5N1 transmission to poultry or wildlife sanctuaries` (id `019f776d-f69b-75cf-93b1-ae8e6c95e559`). New Zealand has confirmed its first two cases of H5N1, and is now requiring biosecurity plans from its poultry sector. Let's look into the New Zealand situation in detail. Let's search for "H5N1" "New Zealand" July 2026.

Excellent! Let's fetch the `afludiary` blog post about New Zealand's new requirement for poultry biosecurity plans and Australia's rising H5N1 count to get exact details and quotes.

This is an exceptional amount of primary evidence and directly addresses our ongoing watches. Let's double check if there are any other notes we should write or if we can update the existing ones. We have: 1. `hhs-clinical-trials-reform-operation-trailblazer` (HHS and FDA's "Operation Trailblazer") - This is already written, no major changes there. 2. `fda-crl-public-disclosure-policy` (FDA Resumes Controversial Complete Response Letter Transparency Policy After Three-Month Pause) - No changes. 3. `saol-therapeutics-sl1009-mitochondrial-disease-fda-acceptance` (FDA Accepts Saol's Resubmitted NDA for SL1009) - No changes. 4. `amgen-tavneos-retraction-ema-revocation-hearing-deadline` (Amgen's Tavneos Faces Retraction and EMA Revocation Ahead of Critical FDA Hearing Deadline) - We have a major update here! On July 23, 2026, Amgen formally submitted its data package to the FDA to challenge the proposed withdrawal of Tavneos. We should update this note with the new details of Amgen's submitted defense package, including the third-party Duke Clinical Research Institute review, real-world analyses, and post-marketing safety data. Let's also look at the other active watches we can resolve or record events for: - `FDA advisory committee meeting for Capricor's deramiocel in DMD cardiomyopathy` (id `019f061f-f34a-7079-a276-d216329928b2`): - This watch has fired because the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) met today, July 29, 2026, and voted 9 to 3 against the efficacy of deramiocel in DMD cardiomyopathy. - I will call `record_event` to resolve this thread. - I will also write a finding for Capricor's deramiocel adcomm outcome under the slug `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-vote`. - `Australia H5N1 transmission to poultry or local wildlife` (id `019f2f50-7f4d-7361-8f05-cdf170c2d727`): - This watch has fired because Australia's Chief Veterinary Officer confirmed H5N1 in 7 greater crested terns in South Australia, bringing the total confirmed or presumed positive detections to 27, and on July 29, 2026, Australia confirmed local transmission of H5N1 bird flu in its native wild bird population. - I will call `record_event` with `resolves: false` (since it's an ongoing watch tracking spread). - I will write a finding under the slug `australia-new-zealand-h5n1-avian-influenza-spread` or a similar durable slug to track this outbreak. - `New Zealand H5N1 transmission to poultry or wildlife sanctuaries` (id `019f776d-f69b-75cf-93b1-ae8e6c95e559`): - This watch has fired because New Zealand has confirmed its second detection of H5N1 and has announced new biosecurity regulations requiring poultry operators with more than 100 birds to develop, register, and implement a farm biosecurity plan for avian disease by the end of 2026. - I will call `record_event` with `resolves: false` (since it is ongoing). Wait, let's look at the watch: - `CARDIO-TTRansform full dataset presentation at ESC Congress 2026` (id `019f490e-b47d-7dea-817e-56ffbad19c83`): scheduled for late August 2026. - `Vera Therapeutics Phase 3 ORIGIN 3 eGFR confirmatory results in IgAN` (id `019f3ec3-9518-7baa-a4e4-19e437e0557f`): expected in Q3 2026. Wait, on July 7, 2026, Vera Therapeutics received FDA accelerated approval for Trutakna (atacicept-vymj) in primary IgA nephropathy. This is a massive milestone! Let's write a finding for this under the slug `vera-therapeutics-trutakna-atacicept-igan-fda-approval`. Let's also see if there are any other watches that have fired: - `FDA advisory committee meeting scheduled for late July 2026 to discuss Replimune's resubmitted BLA for RP1 in advanced melanoma, ahead of the August 2, 2026 PDUFA target action date` (id `019f0620-007b-7dab-87b4-0363a2496ea1`): - The adcomm is scheduled for tomorrow, July 30, 2026. However, the FDA staff briefing documents were released on July 28, 2026, and they are highly critical of RP1's efficacy claim. - We can write a finding about this or update a note, and record that the briefing documents have landed. Let's write a finding about Replimune's RP1 briefing documents under the slug `replimune-rp1-vusolimogene-melanoma-regulatory-scrutiny`. Let's start by recording events for the watches that have fired: 1. Capricor's deramiocel adcomm (one-shot): - id: `019f061f-f34a-7079-a276-d216329928b2` - summary: FDA CTGTAC voted 9-3 against deramiocel's efficacy in DMD cardiomyopathy on July 29, 2026. - outcome: Voted 9-3 against approval due to statistical disputes and fragile efficacy data. - resolves: true 2. Australia H5N1 transmission (ongoing): - id: `019f2f50-7f4d-7361-8f05-cdf170c2d727` - summary: Australia confirms local transmission of H5N1 in native greater crested terns in South Australia. - outcome: Local transmission confirmed in wild seabird population; total H5N1 detections rise to 27. - resolves: false 3. New Zealand H5N1 transmission (ongoing): - id: `019f776d-f69b-75cf-93b1-ae8e6c95e559` - summary: New Zealand implements mandatory biosecurity plans for poultry sector after confirming wild bird cases. - outcome: Mandated farm biosecurity plans for flocks > 100 birds by end of 2026; no government compensation. - resolves: false Let's invoke `record_event` for each of these.

Now let's record the event for Australia H5N1 transmission.

Now let's record the event for New Zealand H5N1 transmission.

Now let's resolve the thread for Capricor's deramiocel adcomm since the meeting occurred today and the panel voted. Wait, there's another thread: `FDA final regulatory decision on Capricor's deramiocel BLA in DMD cardiomyopathy` (id `019faae7-d4d4-7d74-a6b7-85d81f6821f0`). That watch's fire date is `2026-08-31T00:00:00Z` (PDUFA is August 22, 2026). That watch should remain open until the FDA takes its final action. Let's resolve the thread for the advisory committee meeting itself (id `019f061f-f34a-7079-a276-d216329928b2`). Since it was a watch, recording the event with `resolves: true` already handles it! Let's check if there are other threads we should resolve. No other threads are directly resolved yet, but we will check if any other thread can be resolved. Wait, let's write our findings. First, we will write a finding for Capricor's deramiocel adcomm vote outcome. Let's name the slug: `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-vote` Wait, let's check the formatting requirements for the finding: - "name and link the actual thing (the story, article, paper, or page that was posted/published) — not just 'the discussion'" - "carry 1-2 REPRESENTATIVE VERBATIM QUOTES, copied exactly, each kept with the link it came from" - "then say what it means." - "No YAML frontmatter — the title is the first `# ` heading and the slug is the slug parameter you pass." - Wikilinks to other findings are written as `[[its-slug]]`. Let's write the note for Capricor's deramiocel: Title: "FDA Advisory Committee Recommends Against Approval of Capricor's Deramiocel in DMD Cardiomyopathy" Let's compose the note and call `write_note`. Let's review the exact quotes from the Fierce Biotech article we fetched. Quote 1: "The panel voted nine to three against deramiocel, capping off an advisory committee marked by statistical confusion." "As a scientist I would have voted no," Snyder said when explaining his decision. As a clinician, however, "I voted a highly qualified yes, because I don't want methodologic issues to close the door on something that could have something there." (Snyder is Evan Snyder, M.D., Ph.D., acting chair of the CTGTAC) Quote 2: "In some ways, this discussion is sort of moot, in as much as the sponsors' analysis, as presented in The Lancet and presented to us, show that they did not meet this endpoint statistically," committee member John Teerlink, M.D., a cardiologist at the San Francisco Veterans Affairs Medical Center,” said during the discussion. Let's write this note.

Now let's update the existing note on Amgen's Tavneos: `amgen-tavneos-retraction-ema-revocation-hearing-deadline`. Wait, let's read the current content of `amgen-tavneos-retraction-ema-revocation-hearing-deadline` first. Oh wait, `read_notes` can help us get the current content of this note or we can just fetch it. Let's first search or list the notes to check if we can read its exact content to preserve the history while updating. Wait, `read_notes` lists the current set of notes. Let's call `read_notes` to see what notes are in the system.

This is an extremely comprehensive set of notes. Let's see how we can update and refine. First, let's look at the Amgen Tavneos notes. We have: - `amgen-tavneos-retraction-ema-revocation-hearing-deadline` (Amgen's Tavneos Faces Retraction and EMA Revocation Ahead of Critical FDA Hearing Deadline, updated on July 26, 2026). Let's see: on July 23, 2026, Amgen formally submitted its data package to the U.S. Food and Drug Administration (FDA) in support of its request for a formal hearing, challenging the proposed withdrawal of Tavneos. Wait, let's read the note `amgen-tavneos-retraction-ema-revocation-hearing-deadline` body using `read_notes` or we can just overwrite/update it with the latest details since we know the details. Wait! The prompt says: "When this cycle advances a subject you already have a finding for, call write_note with that SAME slug to revise it in place — an upsert that snapshots a new revision." Let's write a revised finding for `amgen-tavneos-retraction-ema-revocation-hearing-deadline`. Let's describe what is happening: - On July 23, 2026, Amgen submitted its extensive data package and scientific analyses to the FDA to defend Tavneos (avacopan) against the proposed withdrawal. - The package includes an independent re-examination of the pivotal Phase 3 ADVOCATE study conducted by the Duke Clinical Research Institute (DCRI). The DCRI review confirmed the noninferiority of Tavneos versus a prednisone taper for remission at Week 26 and sustained remission at Week 52, though it did not demonstrate superiority at Week 52 as originally claimed. - Amgen also submitted real-world evidence (a comparative effectiveness study and a meta-analysis of 71 studies published on medRxiv on July 22, 2026) and post-marketing safety data from its global safety database. - The post-marketing safety data showed serious hepatic adverse events reported at a rate of 31 events per 1,000 patient-years, with most being reversible, though serious liver injuries and deaths were noted (predominantly in elderly Japanese patients). - This is a major update showing how Amgen is fighting to keep the drug on the market and the scientific arguments they are using. Let's write this updated note for `amgen-tavneos-retraction-ema-revocation-hearing-deadline`. Let's construct it beautifully.

Now let's update the existing note for H5N1 bird flu in Australia and New Zealand. Wait, let's see what notes we have: - `h5n1-avian-influenza-arrival-new-zealand-australia-poultry-lockdowns` (H5N1 Avian Influenza Situation Escalates in Australia and New Zealand as Detections Rise and Sanctuaries Lock Down, updated on July 27, 2026). - `h5n1-avian-influenza-arrival-new-zealand` (H5N1 Avian Influenza Arrives in New Zealand, Triggering Emergency Wildlife Vaccinations, updated on July 24, 2026). - `h5n1-bird-flu-arrival-australia-new-zealand` (H5N1 Bird Flu Arrives in Oceania: First Local Detections Confirmed in Australia and New Zealand, updated on July 22, 2026). - `australia-h5n1-avian-influenza-seabirds` (Australia's H5N1 Bird Flu Cases in Migratory Seabirds Grow to Eight as Surveillance Ramps Up, updated on July 23, 2026). - `australia-h5n1-wildlife-transmission` (Australia H5N1 Escalation: First Case Confirmed in Local Native Seabird on Mainland, updated on July 13, 2026). Let's see: `h5n1-avian-influenza-arrival-new-zealand-australia-poultry-lockdowns` is the most recent comprehensive note. Let's update this note to capture the brand new, highly consequential developments: 1. Australia has officially confirmed local transmission of H5N1 bird flu among native wild birds (specifically 7 greater crested terns in South Australia), bringing the total confirmed or presumed positive detections to 27 wild seabirds across four states (South Australia, Victoria, Western Australia, and Queensland). 2. Queensland became the fourth Australian state to confirm a case of H5N1 in a migratory seabird. 3. New Zealand has introduced strict new biosecurity regulations, mandating that all poultry operators with more than 100 birds develop, register, and implement a formal farm biosecurity plan for avian disease by the end of 2026. This comes as officials warn that the virus is highly likely to establish in wild birds, and the government has warned farmers that they will not receive compensation for bird flu losses. Let's write an updated note for `h5n1-avian-influenza-arrival-new-zealand-australia-poultry-lockdowns` to capture these major updates. Let's make sure it has the required format and links.

Now let's check if we can write a finding about the Nancy Grace Roman Space Telescope. Wait, let's look at the prior findings or if we have a note about it. No, we don't have a note about the Roman Space Telescope yet. Let's write a new finding under a durable slug, such as `nasa-nancy-grace-roman-space-telescope-launch`. Let's review the details: - Fueling was successfully completed as of July 27, 2026, at NASA's Kennedy Space Center (loading 290 gallons of hydrazine). - Launch is officially scheduled for August 30, 2026, at 7:26 AM EDT, aboard a SpaceX Falcon Heavy rocket from Launch Complex 39A. - The telescope is launching 8 to 9 months ahead of schedule and under budget. - It is an infrared observatory with a field of view 100 times wider than Hubble's. - It features the CGI (Coronagraph Instrument), which is the best stellar coronagraph ever built and will serve as a key technological precursor for the Habitable Worlds Observatory (HWO). Let's write this finding! This is a major scientific breakthrough and milestone. Let's make sure it is written in the correct format.

Now let's see if there are other watches we can register. Wait! Let's register a new watch for the Nancy Grace Roman Space Telescope launch on August 30, 2026. This is a dated catalyst. Let's call `record_watch`: - watch_type: `dated_catalyst` - cardinality: `one_shot` - title: `Launch of NASA's Nancy Grace Roman Space Telescope` - entity: `NASA / SpaceX` - fire_date: `2026-08-30T11:26:00Z` - description: `Monitor the launch of the Nancy Grace Roman Space Telescope aboard a SpaceX Falcon Heavy rocket, scheduled for August 30, 2026.` Let's call this.

This is perfect. Now let's check if there are any other topics to record or if we have covered everything. Wait, let's look at the active watches list. We have: - `Vera Therapeutics Phase 3 ORIGIN 3 eGFR confirmatory results in IgAN` (id `019f3ec3-9518-7baa-a4e4-19e437e0557f`): We know that Vera's Trutakna received FDA accelerated approval on July 7, 2026. This is a massive milestone! Let's write a finding about this approval, and since we already have a watch for the confirmatory trial results, we can link it. Wait, do we have a note for Trutakna's approval? Let's see: `vera-therapeutics-trutakna-fda-approval-igan` (Vera Therapeutics' BAFF/APRIL Inhibitor TRUTAKNA Wins FDA Accelerated Approval in IgAN, updated on July 28, 2026) and `vera-trutakna-fda-accelerated-approval-igan` (Vera's Trutakna (Atacicept) Wins FDA Accelerated Approval for IgA Nephropathy, updated on July 23, 2026). Ah! There are two very similar slugs in the system: `vera-therapeutics-trutakna-fda-approval-igan` and `vera-trutakna-fda-accelerated-approval-igan`. The rule says: "Before you write, scan your prior findings (the injected block + read_notes) for the slug that already owns this subject and reuse it; if you find yourself coining a near-synonym of an existing slug, stop and reuse the existing one." The most recently updated one is `vera-therapeutics-trutakna-fda-approval-igan` (updated on July 28, 2026). Let's check its content by updating it with the final details of the approval from the press release and the Lancet publication (NEJM publication, actually, NEJM published the Phase 3 trial: Lafayette R, et al. N Engl J Med 2026). Wait, let's write a comprehensive update to `vera-therapeutics-trutakna-fda-approval-igan` to make sure it is perfectly polished and captures the details of the July 7, 2026 accelerated approval. Let's make sure it has the required format and references.

This is excellent. Let's see: we have written or updated all the notes that have had major developments this cycle: 1. Updated `amgen-tavneos-retraction-ema-revocation-hearing-deadline` (Amgen Formally Submits DCRI Re-Analysis and Real-World Data to FDA to Defend Tavneos Against Withdrawal) with the July 23, 2026 data package details. 2. Updated `h5n1-avian-influenza-arrival-new-zealand-australia-poultry-lockdowns` (H5N1 Avian Influenza Situation Escalates in Australia and New Zealand as Local Transmission Confirmed and Poultry Regulations Mandated) with Australia's confirmation of local transmission in native wild birds and New Zealand's new mandatory biosecurity regulations. 3. Created `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-vote` (FDA Advisory Committee Recommends Against Approval of Capricor's Deramiocel in DMD Cardiomyopathy) capturing the 9-3 CTGTAC vote against deramiocel's efficacy today, July 29, 2026. 4. Created `nasa-nancy-grace-roman-space-telescope-launch` (NASA's Nancy Grace Roman Space Telescope Completes Fueling, Ready for August 30 Launch) capturing the successful pre-launch fueling of the flagship telescope. 5. Updated `vera-therapeutics-trutakna-fda-approval-igan` (Vera Therapeutics' BAFF/APRIL Inhibitor TRUTAKNA Wins FDA Accelerated Approval in IgAN) with precise quotes and trial details. Let's do a quick scan to make sure there are no other threads we need to record or resolve. We have: - `FDA advisory committee meeting for Capricor's deramiocel in DMD cardiomyopathy` (id `019f061f-f34a-7079-a276-d216329928b2`): This watch has been resolved because the meeting occurred and the vote was taken, which we recorded. Wait, let's look at: `FDA advisory committee meeting scheduled for late July 2026 to discuss Replimune's resubmitted BLA for RP1 in advanced melanoma, ahead of the August 2, 2026 PDUFA target action date` (id `019f0620-007b-7dab-87b4-0363a2496ea1`). The meeting is scheduled for tomorrow, July 30, 2026. Since the meeting has not occurred yet (today is July 29, 2026), we should keep this watch open and check it in the next cycle. Let's call `finish_cycle` to complete this research cycle! This is the only way to end a cycle. Let's do it now.

I have completed the research cycle for topic `019e92c9-9dac-7a47-a1f2-f8f4037c94f9`. ### Summary of Actions in This Cycle: 1. **Recorded Events on Active Watches**: - **Capricor's Deramiocel FDA AdCom Meeting** (Resolved): Recorded that the Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) met on July 29, 2026, and voted 9–3 against recommending the approval of deramiocel for DMD cardiomyopathy. - **Australia H5N1 Transmission** (Ongoing): Recorded that Australia’s Chief Veterinary Officer confirmed local transmission of H5N1 among native greater crested terns in South Australia. - **New Zealand H5N1 Transmission** (Ongoing): Recorded that New Zealand has introduced strict new biosecurity mandates for poultry operators with more than 100 birds in response to the virus's arrival. 2. **Registered a New Watch**: - **Launch of NASA's Nancy Grace Roman Space Telescope** (One-shot, Target: August 30, 2026): Registered a watch to track the upcoming launch of NASA's next flagship infrared observatory aboard a SpaceX Falcon Heavy. 3. **Created and Updated Research Findings (Notes)**: - **Capricor's Deramiocel AdCom Vote** (New Note: `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-vote`): Documented the 9–3 negative vote, the statistical disputes over the HOPE-3 trial data, and comments from panel members. - **Amgen's Tavneos Defense** (Updated Note: `amgen-tavneos-retraction-ema-revocation-hearing-deadline`): Captured Amgen's formal July 23, 2026 submission of its clinical defense package, including the Duke Clinical Research Institute's independent trial re-evaluation and real-world medRxiv preprints. - **H5N1 Spread in Oceania** (Updated Note: `h5n1-avian-influenza-arrival-new-zealand-australia-poultry-lockdowns`): Expanded the bird flu situation to report on Australia's local transmission in native wild birds and New Zealand's new mandatory farm biosecurity plans. - **Nancy Grace Roman Space Telescope** (New Note: `nasa-nancy-grace-roman-space-telescope-launch`): Documented the successful fueling of the telescope at Kennedy Space Center and its readiness for an August 30, 2026 launch. - **Vera Therapeutics' Trutakna Approval** (Updated Note: `vera-therapeutics-trutakna-fda-approval-igan`): Refined and polished the details of Trutakna's landmark July 7, 2026 FDA accelerated approval in IgA nephropathy.